⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

LLY

Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,273.46USD

-33.2300 (-2.54%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on LLY.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 1,273.46
P/E42.5
Dvd Ind Yld0.5%
P/B33.50
P/S14.2
Curr EV/T12M EBITDA28.3
Mkt Cap (USD)1,135.1B
Curr EV (USD)1,181.1B
2)

Per Share Data

EPS T12M29.79
DPS6.47
Bk Val Per Sh38.00
Rev/Sh89.14
Cash/Sh10.04
Curr Shares Out891.4M
FCF/Sh6.56
3)

Cash Flow Analysis

P/CF40.4
Curr P/FCF193.6
CF/NI1.1
Dvd P/O21.7%
Cash Gen/Cash Reqd3.8
Csh Dvd Cov4.9
CFO/Sales35.3%
Eff Interest Rate1.9%
4)

Growth Potential

Dil EPS 1Y Gr96.0%
Cap 1Y Gr44.1%
BPS 1Y Gr86.9%
R&D To Sales10.2%
Retention Rate78.3%
Rev 1Y Gr44.7%
FCF 1Y Gr—
Assets 1Y Gr42.9%
5)

Profitability

EBITDA41.7B
EBIT—
Operating Margin54.2%
Pretax Margin42.2%
Net Margin33.5%
ROA22.0%
ROE102.4%
ROC—
Asset Turnover0.66
6)

Structure

Current Ratio1.35
Quick Ratio0.68
Debt/Assets38.6%
Debt/Com Eq162.1%
Net Debt/EBITDA1.10
Tot Debt/Capital61.8%
Gross Margin83.4%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.